Combined hepatitis A and B vaccine: providing a bright future for preventing hepatitis
Combined hepatitis A and B vaccine: providing a bright future for preventing hepatitis
复制标题
DOI：
10.1517/14712590903160639
复制
发表时间：
2009-09-01
影响因子：
4.6
通讯作者：
Hewlett, Alex T.
中科院分区：
文献类型：
--
作者：
Hewlett, Alex T.
自2001年以来，美国已经推出了第一种甲型和乙型肝炎联合疫苗。该疫苗具有快速的血清保护和持久的免疫原性，可预防病毒性肝炎。这篇综述概述了该产品的成分、临床疗效以及在特殊情况下的使用机会。该疫苗具有良好的安全性和耐受性。甲型和乙型肝炎联合疫苗是一种经过充分研究的疫苗，提供了快速的血清转换和良好的安全性。
The first combined hepatitis A and B vaccine has been available in the United States since 2001. The vaccine provides protection against viral hepatitis with rapid seroprotection and lasting immunogenicity. This review outlines the product's components, clinical efficacy and opportunities for use in special circumstances. The vaccine has a good safety profile and has good tolerability. The combined hepatitis A and B vaccine is a well studied vaccine that provides rapid seroconversion with a good safety profile.